Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03092310 · ClinicalTrials.gov registry record · NA
Feasibility Evaluation of an Artificial Pancreas With Glucose Prediction Trust Index
A NA study, sponsored by Sansum Diabetes Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03092310 is a NA study that has completed, run by Sansum Diabetes Research Institute. The registered enrollment target is 15 participants.
The verdict
NCT03092310, a NA study, has completed, sponsored by Sansum Diabetes Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to establish that closed-loop insulin delivery with a target enchanted model predictive control (eMPC)/Health Monitoring System (HMS) algorithms with a trust index of the predicted glucose value is safe and effective, to analyze and learn to improve upon the accuracy of the predicted glucose values, and to collect efficacy data to inform a future larger study.
Interventions
- DEVICE Artificial Pancreas Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-03-20 |
| Est. Completion | 2017-12-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03092310
The ClinicalTrials.gov registry entry for NCT03092310 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sansum Diabetes Research Institute, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Artificial Pancreas Device is the first listed.
NCT03092310 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03092310 about?
NCT03092310 is a clinical study titled "Feasibility Evaluation of an Artificial Pancreas With Glucose Prediction Trust Index". The purpose of this pilot study is to establish that closed-loop insulin delivery with a target enchanted model predictive control (eMPC)/Health Monitoring System (HMS) algorithms with a trust index of the predicted glucose value is safe and effective, to analyze and learn to improve upon the accura...
What is the current status of trial NCT03092310?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2017-03-20. Estimated completion is 2017-12-20.
What interventions are being tested in trial NCT03092310?
The interventions under investigation include: Artificial Pancreas Device (DEVICE).
Who is sponsoring clinical trial NCT03092310?
This trial is sponsored by Sansum Diabetes Research Institute, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.